Trace amines such as p-tyramine, p-octopamine and p-synephrine are found in low concentrations in animals and plants. Consumption of pre-workout supplements containing these plant-derived amines has been associated with cardiovascular side effects. The aim of this study was to determine the mechanisms of action of these trace amines on porcine isolated coronary and mesenteric arteries. Noradrenaline caused contraction of mesenteric arteries and relaxation of coronary arteries. In both tissues, all three trace amines induced contractions with similar potencies and responses were unaffected by the β-adrenoceptor antagonist propranolol (1 µM), the nitric oxide synthase inhibitor L-NNA (100 µM), or the TAAR-1 antagonist, EPPTB (100 nM). However, the contractile responses of mesenteric arteries, but not coronary arteries, were significantly reduced by depletion of endogenous noradrenaline. Mesenteric responses to all three amines were abolished in the presence of prazosin (1 µM) whereas residual contractile responses remained in the coronary artery which were inhibited by a high concentration (100 µM) of EPPTB. The results suggest complex responses of the coronary artery to the trace amines, with activity at α 1 -adrenoceptors and potentially TAARs other than TAAR-1. In contrast the actions of the amines on the mesenteric artery appeared to involve indirect sympathomimetic actions and direct actions on α 1 -adrenoceptors. p-Tyramine (tyramine), p-octopamine (octopamine) and p-synephrine (synephrine) are substituted phenethylamines with a phenolic hydroxyl group in the para-position (Fig. 
that tyramine and octopamine acts directly on TAARs to cause vasoconstriction in endothelium-denuded rat aortas 15, 16 and pig coronary arteries 17 , but no selective antagonists were available to investigate this hypothesis. The presence of specific tyramine receptors had previously been proposed to explain rat aortic responses to synephrine that were resistant to conventional receptor antagonists 8 . Thus, there is some indirect evidence to suggest that tyramine and synephrine may induce some vascular responses via specific receptors.
The aim of the present study was to investigate the actions and mechanisms of action of the trace amines on the mesenteric and coronary artery using a porcine model. The mesenteric artery is densely innervated by the sympathetic nerves, and is a major regulator of blood flow to the gastrointestinal system during physiological stress 18 . Blood flow to the intestine can be drastically reduced (>80%) during exercise which results in the shunting of blood to the skeletal and cardiac muscle 19 . In contrast, during physiological stress the adrenergic nervous system ensures an increased blood flow to cardiac muscle via the coronary circulation 20, 21 . Thus, in this study, the relative potencies of the trace amines tyramine, octopamine and synephrine were investigated on the vascular tone of mesenteric artery and the coronary artery and the mechanisms of action for each amine in the two functionally very different arteries determined. The role of TAAR-1 in responses was also examined using EPPTB (RO-5212773), a recently developed selective antagonist for TAAR-1 22 .
Results
Responses of the porcine mesenteric artery. All three trace amines produced concentration-dependent contractions of the porcine arterial rings (Fig. 2 ). Tyramine and synephrine produced similar maximum responses, whilst those to octopamine were significantly greater (unpaired Welch's t-test, p < 0.05). All three trace amines had similar potencies that were not significantly different (pEC50 ranging from 3.25-3.91). The endogenous amine, noradrenaline produced greater contractions than the three trace amines and was also the most potent drug tested (Fig. 2 , Table 1 ).
Responses of the porcine coronary artery. All three trace amines produced concentration-dependent contractions of porcine coronary arterial rings (Fig. 3 ). Octopamine and synephrine produced similar maximum responses, whilst those to tyramine were greater, the difference between tyramine and octopamine being statistically significant (p < 0.05). The potencies of all three amines were similar and ranged from 3.30-3.88 (Table 2) . The amines shown are tyramine (• n = 6), synephrine (■, n = 6) and octopamine (▲, n = 6). The data are presented as percent of contraction to 60 mM potassium chloride (%KCl). Welch corrected unpaired t-test, *, p < 0.05 vs. tyramine; ^, p < 0.05 vs. synephrine.
The endogenous amine noradrenaline failed to produce contraction and only relaxations were observed (Fig. 3) . These relaxations were converted to contractions in the presence of the β-adrenoceptor antagonist propranolol (1 µM). The maximum contractile responses to noradrenaline (33.4 ± 2.7% of the response to potassium) were significantly greater than those to octopamine (20.3 ± 4.6%, p < 0.05) and synephrine (21.1 ± 7.3%, p < 0.05), but not tyramine (32.3 ± 4.5%). In the presence of both propranolol (1 µM) and the α 1 -adrenoceptor antagonist prazosin (1 µM) responses to noradrenaline were abolished completely.
The role of endogenous noradrenaline release in responses in mesenteric artery. In mesenteric arteries, tyramine pre-treatment for 30 minutes nearly abolished subsequent responses to tyramine with a > 90% reduction in maximal contraction and a rightward shift of curves (pEC50 value 2.87 ± 0.06, n = 6; Student's t-test p < 0.05) (Fig. 4) . In tissues depleted of endogenous noradrenaline, the maximal contractions to synephrine were reduced by 58% and maximal responses to octopamine were halved. However, the 30-minute tyramine pre-treatment did not affect the potencies (pEC50 values) of either synephrine or octopamine (Fig. 4) . The contractile responses to exogenous noradrenaline were not significantly affected by tyramine pre-treatment (Table 1) . To examine whether responses to any of the trace amines involved the release of nitric oxide, tissues were incubated with the nitric oxide synthase inhibitor, L-NNA (100 µM). None of the responses to the trace amines was affected by the removal of nitric oxide ( Table 1) .
The role of endogenous noradrenaline release in responses in coronary artery. Tyramine pre-treatment did not affect the potencies or maximal contractions to either tyramine itself or synephrine (Fig. 4 , Table 2 ). Noradrenaline depletion did appear to reduce responses to octopamine by about 50%, but the change was not statistically significant (Fig. 4) . None of the responses to the amines was affected by the removal of nitric oxide with L-NNA ( Table 2) .
Role of direct adrenoceptor stimulation in trace amine-induced vasoconstriction in mesenteric artery. In noradrenaline-depleted mesenteric artery rings the presence of the α 1 -adrenoceptor antagonist prazosin (1 µM) abolished the responses to all three trace amines (Fig. 5, Table 1 ). Prazosin caused a rightward shift of concentration-response curves to noradrenaline (P < 0.05) without affecting maximum responses (Table 1) . Neither maximum contractile responses nor potencies for any of the trace amines or noradrenaline were changed in the presence of propranolol (1 µM) ( Table 1) .
Role of direct adrenoceptor stimulation in trace amine-induced vasoconstriction in coronary artery. In noradrenaline-depleted coronary artery rings the presence of prazosin (1 µM) reduced maximum contractions produced by tyramine, octopamine and synephrine by about half without significantly affecting agonist potency (Fig. 5, Table 2 ). Contractile responses to synephrine were the most significantly affected by prazosin, but responses were again not completely abolished. Neither maximum contractile responses nor potencies for any of the amines changed significantly in the presence of propranolol (1 µM) ( Table 2) .
Trace amine and interventions

Controls Treatment
Sample number (n) Max contraction (%KCl) Potency (pEC50) Max contraction (%KCl) Potency (pEC50)
Tyramine
Tyramine pre-treatment (3 mM) 30.0 ± 3.9 3.91 ± 0.14 2.9 ± 0. www.nature.com/scientificreports www.nature.com/scientificreports/ Role of Trace amine-associated receptor 1 (TAAR-1) in trace amine-induced vasoconstriction of coronary artery. In noradrenaline-depleted tissues,the possible involvement of the TAAR-1 receptor in mediating responses was investigated using the selective TAAR-1 antagonist EPPTB (Fig. 6 , Table 2 ). The effects of this antagonist were dependent on the concentration of the antagonist. At the lower concentration (100 nM), EPPTB did not reduce responses to any of the trace amines, and for tyramine, responses were greater in the presence of this antagonist, although the change was not statistically significant.
The higher concentration of EPPTB (100 µM) did not affect pEC50 values for any of the amines but reduced maximum responses to both tyramine and synephrine by 70%, whilst responses to octopamine were reduced by 53% (Fig. 6 , Table 2 ).
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Discussion
All three trace amines contracted the mesenteric artery but were weaker and less potent than the biogenic amine noradrenaline. The potency order for the amines was noradrenaline > tyramine = synephrine = octopamine where the differences between the three trace amines were not significantly different. Previously vasoconstrictor effects of tyramine on canine mesenteric arteries 23, 24 and octopamine on rat mesenteric arterioles 25 have been observed, but the vascular effects of synephrine are unclear. Huang et al. (1995) reported that synephrine was incapable of producing contractions of isolated rat mesenteric arteries 26 , but in our study synephrine produced concentration-dependent vasoconstrictions of the porcine mesenteric artery, suggesting that species differences may occur. In the same study by Huang and colleagues, a Citrus aurantium extract caused dose-dependent www.nature.com/scientificreports www.nature.com/scientificreports/ vasocontractions of the rat mesenteric artery with a maximum value of 27 ± 3% (% 60 mM KCl), a value similar to the maximum contractions observed in the responses to synephrine in this current study. In contrast to our experiments on isolated mesenteric arteries, Anwar and colleagues showed a vasodilatory response in perfused rat mesenteric beds 6 . The discrepancy between the reports may be a result of differences in perivascular nerve distribution, as there is a greater density in non-adrenergic non-cholinergic nerves 2 nd and 3 rd branches of mesenteric arteries 27 . Thus differences between the Anwar study and our study may be explained by differences in species (rat vs pig) of type of vessel examined (perfused vascular bed vs larger artery).
On the coronary artery, all three trace amines were partial agonists and contracted the tissues with potencies similar to those seen on the mesenteric artery (ie. pEC50 range 3.3-4.0). The observations for tyramine were consistent with previous studies on the porcine coronary artery 17 and the rat aorta 8, 9, 15 . However, unlike the mesenteric artery, the left anterior coronary artery contains a high proportion of β 2 -adrenoceptors and relatively few α 1 -adrenoceptors 28 and noradrenaline administered to control arteries caused vasorelaxation, which would be consistent with predominant β 2 -adrenoceptor activation. In the presence of the β-adrenoceptor antagonist, propranolol, the responses to noradrenaline were reversed to vasoconstriction. The constriction of the coronary smooth muscle in response to noradrenaline was caused by α 1 -adrenoceptors as evidenced by the abolition of responses in the presence of the α 1 -adrenoceptor antagonist prazosin. In contrast to noradrenaline, propranolol did not affect the responses to the trace amines, and even in the presence of prazosin, these amines could produce coronary artery vasoconstriction suggesting a non-adrenoceptor mechanism of action.
To further investigate the mechanisms involved in the vasoconstriction induced by the trace amines, the contribution of indirect actions and direct adrenoceptor activity were examined. The inhibition of NO synthase did not significantly affect responses to any of the amines indicating they did not stimulate release of NO. However, depletion of sympathetic stores of noradrenaline did have an effect and has been shown to greatly reduce the responses of tissues to indirectly acting sympathomimetic drugs 29, 30 . Tyramine was first described as an indirectly acting sympathomimetic drug by Burn and Rand (1958) , who showed that the depletion of endogenous noradrenaline stores, completely abolished the effects of tyramine but not directly acting amines 31 . The mesenteric vasculature contains a dense neuronal network that would redirect blood flow away from the intestine during sympathetic nervous system activation 18 . The incubation of porcine mesenteric arteries with a high concentration (3 mM) of tyramine for 30 minutes almost abolished subsequent responses of tissues to tyramine, indicating that stores of noradrenaline were depleted. Responses to exogenous noradrenaline were not affected by prior depletion of noradrenaline stores, demonstrating direct activation of α-adrenoceptors by noradrenaline caused vasoconstriction. In contrast, the responses to octopamine and synephrine were halved in noradrenaline-depleted tissues, suggesting that, like tyramine, the release of endogenous noradrenaline from sympathetic nerves contributes, at least partially, to the responses of these mesenteric vessels to these trace amines.
Different results were obtained in the coronary arteries where the three trace amines continued to elicit significant responses after incubations to deplete endogenous noradrenaline stores. Responses to tyramine were almost identical in control and noradrenaline-depletion tissues, however responses to octopamine and synephrine appeared to be reduced slightly but the changes were small and not statistically significant. These results suggest that in the coronary artery, unlike the mesenteric artery, the release of endogenous noradrenaline from sympathetic nerves does not contribute significantly to the responses of coronary vessels to trace amines. This www.nature.com/scientificreports www.nature.com/scientificreports/ conclusion was further supported by the finding that the response of the coronary artery to noradrenaline in the absence of antagonists was relaxation, making it impossible for the release of endogenous noradrenaline to cause the contractile responses to the trace amines.
In mesenteric arteries the small contractile responses to the trace amines remaining after noradrenaline depletion were not affected by the β-adrenoceptor antagonist, propranolol, but were abolished in the presence of prazosin. This indicates that the amines lacked significant effects on vascular β-adrenoceptors in this tissue and that the residual contractile effects after noradrenaline depletion were mediated via α 1 -adrenoceptor stimulation. It has previously been reported that responses of the coronary artery to the trace amines, tyramine and β-phenylethylamine (β-PEA) were not affected by either prazosin or propranolol 17 , suggesting a lack of adrenoceptor involvement in responses. However, the coronary responses to synephrine and octopamine were not explored. In the present study, the maximum contractions of coronary arteries to all three trace amines were significantly reduced by prazosin indicating a weak partial agonist action at the α 1 -adrenoceptors of this tissue. These results are consistent with previous data using rat aorta where octopamine and synephrine activated α 1 -adrenoceptors to cause contraction 7, 9, 15 . However, the residual vasoconstrictions to these three amines in the presence of prazosin suggests the involvement of another non-adrenergic receptor. Other monoamines such as 5-HT, histamine and dopamine are known to cause constriction of pig coronary arteries, but blockade of their respective receptors does not affect responses to tyramine or β-PEA
17
. This prompted the authors to propose that these amines were acting on TAARs although an antagonist was not available at the time to test this hypothesis.
The physiological effects of trace amine-associated receptors were first identified in the process of olfaction, but these receptors have since been identified in tissues throughout the body. The TAAR-1 subtype is unusual as it is not involved in olfaction but is involved in neuromodulation and is therefore a potential target for drug development in the treatment of psychiatric and neurodegenerative disorders 32 . Stimulation of TAAR-1 causes activation of the G-protein alpha subunit (Gs) and subsequent increase in cellular cAMP concentration 12 . The selective competitive antagonist for TAAR-1, EPPTB (RO-5212773) was first described by 33 . It has a high affinity for the mouse TAAR-1 (Ki = 0.9 nM) and was employed in the present study at a concentration of 100 nM. The maximum responses to tyramine, but not octopamine or synephrine, appeared to be increased in the presence of 100 nM EPPTB although the effect was not statistically significant. Had tyramine activated TAAR-1 receptors enhanced responses would be expected since the receptor normally inhibits contraction. This would fit with the known activation of adenylyl cyclase following activation of this receptor and the inhibition of contraction by intracellular cAMP. It has been reported that tyramine is more potent at TAAR-1 than octopamine or synephrine 13, 14 . However, the effects of EPPTB are known to be species-dependent 33 since the drug exhibited a high affinity for the mouse variant of TAAR-1 (Ki = 0.9 nM) but a much lower affinity for the rat (Ki = 942 nM) and human TAAR-1 (Ki > 5 µM). The affinity of EPPTB at the porcine receptor is unknown, but we examined a higher concentration of the antagonist that would block responses mediated via the low-affinity variant of this receptor. In the presence of the higher concentration of EPPTB (100 µM), contractile responses to all three trace amines were reduced by more than half. Whether this represents an action of these trace amines at the low affinity TAAR-1 or a non-selective action at other TAAR receptors at higher drug concentrations is not known. Unfortunately, further studies will have to wait until selective drugs at other TAAR subtypes have been developed.
Conclusion
This study has shown that the trace amines, (tyramine, octopamine and synephrine) can induce vasoconstriction by a variety of complex mechanisms including direct α-adrenoceptor activation, indirect actions via release of endogenous noradrenaline and actions at another receptor yet to be identified, with the mechanism depending on the blood vessel. On the mesenteric artery, the trace amines induced contractions via an indirect sympathomimetic action and also a direct α 1 -adrenoceptor agonist mechanism. In the coronary artery, the amines appeared to have almost no indirect sympathomimetic actions but do elicit contractions via weak direct agonist actions on α 1 -adrenoceptors and possibly an action on TAAR receptors other than the TAAR-1 subtype.
Methods and Materials
Tissue preparation. Hearts and gastrointestinal tracts from 5-month-old female pigs were obtained from the local abattoir and transported in ice-cold Krebs-bicarbonate solution to the laboratory. The left anterior descending coronary artery or the inferior mesenteric artery were isolated and 3 mm length rings were suspended between stainless-steel hooks and stationary supports in 8 mL organ bath (EZ-baths, Global Towns, CA) containing Krebs-bicarbonate solution (composition in mM: NaCl 118, NaHCO 3 25, glucose 11.7, MgSO 4 2.4, KH 2 PO 4 1.2, KCl 1.2, CaCl 2 2.5) maintained at 37 °C and continuously oxygenated with 5% CO 2 in oxygen. The rings were mounted under a resting tension of 5 g and the tension developed by the circular smooth muscle in response to the addition of drugs was measured using isometric force transducers coupled to a PowerLab computer system (AD Instruments, Castle Hill, Australia).
Experimental protocol. After equilibrating the tissues for 30 minutes, cumulative concentration-response curves to either noradrenaline, phenylephrine, tyramine, synephrine or octopamine were generated. After washout, responses to the amines were repeated and responses to KCl (60 mM) were obtained at the end of the experiment. Responses were expressed as a percentage of the response to 60 mM KCl.
To investigate the possible indirect sympathomimetic action of these amines; the tissues were incubated with a high concentration of tyramine (3 mM) for 30 minutes to deplete pre-synaptic noradrenaline (NA) stores. After washout, responses to noradrenaline, tyramine, synephrine or octopamine were again obtained.
To investigate the mechanisms involved in the functional actions of these amines; α 1 -or β-adrenoceptor antagonists (prazosin or propranolol respectively; both 1 µM), trace amine-associated receptor 1 antagonist (EPPTB; 100 nM and 100 µM) or the nitric oxide synthase inhibitor, L-Nω-Nitroarginine (L-NNA; 100 µM) were www.nature.com/scientificreports www.nature.com/scientificreports/ added 30 minutes before the addition of agonists. Control experiments without the addition of the antagonist were also performed, but repeated curves to the amines were not significantly different and correction of the second test curve in the presence of the antagonist was not required.
